{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T11:54:05Z","timestamp":1775735645166,"version":"3.50.1"},"reference-count":139,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"National Institutes of HealthNational Institutes of Health (NIH)","award":["R01DK069950"],"award-info":[{"award-number":["R01DK069950"]}]},{"name":"National Institutes of HealthNational Institutes of Health (NIH)","award":["R01DK43140"],"award-info":[{"award-number":["R01DK43140"]}]},{"name":"National Institutes of HealthNational Institutes of Health (NIH)","award":["R01GM086596"],"award-info":[{"award-number":["R01GM086596"]}]},{"name":"National Institutes of HealthNational Institutes of Health (NIH)","award":["1K08DK109116"],"award-info":[{"award-number":["1K08DK109116"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.jsbmb.2019.01.018","type":"journal-article","created":{"date-parts":[[2019,1,29]],"date-time":"2019-01-29T18:16:32Z","timestamp":1548785792000},"page":"273-280","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["Steroid biomarkers in human adrenal disease"],"prefix":"10.1016","volume":"190","author":[{"given":"Juilee","family":"Rege","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adina F.","family":"Turcu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias","family":"Else","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6815-6181","authenticated-orcid":false,"given":"Richard J.","family":"Auchus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William E.","family":"Rainey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsbmb.2019.01.018_bib0005","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/BF01979887","article-title":"Ein beitrag zu der feiner struktur und dem chemismus der nebennieren","volume":"35","author":"Arnold","year":"1866","journal-title":"Virchows Arch."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0010","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/jemt.10331","article-title":"Adrenocortical zonation and ACTH","volume":"61","author":"Vinson","year":"2003","journal-title":"Microsc. Res. Tech."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0015","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1111\/j.1440-1681.1998.tb02308.x","article-title":"Origins of zonation: the adrenocortical model of tissue development and differentiation","volume":"25","author":"Vinson","year":"1998","journal-title":"Clin. Exp. Pharmacol. Physiol. Suppl."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0020","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1749-6632.1995.tb17370.x","article-title":"Biosynthesis of DHEAS by the human adrenal cortex and its age-related decline","volume":"774","author":"Hornsby","year":"1995","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0025","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1210\/edrv-1-4-392","article-title":"Control of adrenal androgen secretion","volume":"1","author":"Parker","year":"1980","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0030","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1210\/jc.2012-2912","article-title":"Liquid chromatography-tandem mass spectrometry analysis of human adrenal vein 19-carbon steroids before and after ACTH stimulation","volume":"98","author":"Rege","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0035","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0303-7207(00)00404-4","article-title":"Differentially expressed genes in zona reticularis cells of the human adrenal cortex","volume":"173","author":"Wang","year":"2001","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0040","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.mce.2008.08.024","article-title":"Angiotensin II regulation of adrenocortical gene transcription","volume":"302","author":"Nogueira","year":"2009","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0045","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0303-7207(85)90123-6","article-title":"Regulation of the biosynthesis of cytochromes P-450 involved in steroid hormone synthesis","volume":"39","author":"Waterman","year":"1985","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0050","doi-asserted-by":"crossref","first-page":"E518","DOI":"10.1210\/jc.2013-3198","article-title":"Transcriptome profiling reveals differentially expressed transcripts between the human adrenal zona fasciculata and zona reticularis","volume":"99","author":"Rege","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0055","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1073\/pnas.89.4.1458","article-title":"Role of steroid 11 beta-hydroxylase and steroid 18-hydroxylase in the biosynthesis of glucocorticoids and mineralocorticoids in humans","volume":"89","author":"Kawamoto","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0060","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1046\/j.1365-2265.2000.01144.x","article-title":"Developmental changes in steroidogenic enzymes in human postnatal adrenal cortex: immunohistochemical studies","volume":"53","author":"Suzuki","year":"2000","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0065","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1080\/07435809609043768","article-title":"Adrenarche is associated with decreased 3 beta-hydroxysteroid dehydrogenase expression in the adrenal reticularis","volume":"22","author":"Gell","year":"1996","journal-title":"Endocr. Res."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0070","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/0002-9378(73)90632-7","article-title":"Ovarian, adrenal, and peripheral testosterone levels in the polycystic ovary syndrome","volume":"117","author":"Stahl","year":"1973","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0075","first-page":"650","article-title":"Serum testosterone levels in hirsute women: a comparison of adrenal, ovarian and peripheral vein values","volume":"41","author":"Stahl","year":"1973","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0080","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/j.1879-3479.1979.tb00120.x","article-title":"The significance of adrenal and ovarian catheterization in patients with polycystic ovary syndrome","volume":"17","author":"Tzingounis","year":"1978","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0085","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S0015-0282(16)41352-X","article-title":"Peripheral, ovarian, and adrenal vein steroids in hirsute women: acute effects of human chorionic gonadotropin and adrenocorticotrophic hormone","volume":"26","author":"Parker","year":"1975","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0090","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1210\/jc.2008-2374","article-title":"Type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3) contributes to testosterone production in the adrenal reticularis","volume":"94","author":"Nakamura","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0095","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1530\/EJE-15-1181","article-title":"Adrenal-derived 11-oxygenated 19-carbon steroids are the dominant androgens in classic 21-hydroxylase deficiency","volume":"174","author":"Turcu","year":"2016","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0100","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1210\/me.2012-1287","article-title":"Structural insights into aldosterone synthase substrate specificity and targeted inhibition","volume":"27","author":"Strushkevich","year":"2013","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0105","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jsbmb.2013.04.010","article-title":"11beta-hydroxyandrostenedione, the product of androstenedione metabolism in the adrenal, is metabolized in LNCaP cells by 5alpha-reductase yielding 11beta-hydroxy-5alpha-androstanedione","volume":"138","author":"Swart","year":"2013","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0110","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.mce.2014.12.009","article-title":"11beta-Hydroxyandrostenedione: downstream metabolism by 11betaHSD, 17betaHSD and SRD5A produces novel substrates in familiar pathways","volume":"408","author":"Swart","year":"2015","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0115","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.mce.2013.07.006","article-title":"11beta-Hydroxydihydrotestosterone and 11-ketodihydrotestosterone, novel C19 steroids with androgenic activity: a putative role in castration resistant prostate cancer?","volume":"377","author":"Storbeck","year":"2013","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0120","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jsbmb.2018.06.013","article-title":"11-Oxygenated androgen precursors are the preferred substrates for aldo-keto reductase 1C3 (AKR1C3): implications for castration resistant prostate cancer","volume":"183","author":"Barnard","year":"2018","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0125","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jsbmb.2015.11.005","article-title":"Development of a novel cell based androgen screening model","volume":"156","author":"Campana","year":"2016","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0130","first-page":"4589","article-title":"11-ketotestosterone is the dominant circulating bioactive androgen during normal and premature adrenarche","volume":"103","author":"Rege","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0135","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ecl.2015.02.002","article-title":"Adrenal steroidogenesis and congenital adrenal hyperplasia","volume":"44","author":"Turcu","year":"2015","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0140","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1056\/NEJMra021561","article-title":"Congenital adrenal hyperplasia","volume":"349","author":"Speiser","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0145","doi-asserted-by":"crossref","first-page":"383","DOI":"10.4158\/EP14474.RA","article-title":"The classic and nonclassic concenital adrenal hyperplasias","volume":"21","author":"Auchus","year":"2015","journal-title":"Endocr. Pract."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0150","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0889-8529(08)70017-3","article-title":"Newborn screening for congenital adrenal hyperplasia","volume":"30","author":"Therrell","year":"2001","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0155","first-page":"650","article-title":"High frequency of nonclassical steroid 21-hydroxylase deficiency","volume":"37","author":"Speiser","year":"1985","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0160","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1038\/gim.2017.46","article-title":"Revisiting the prevalence of nonclassic congenital adrenal hyperplasia in US Ashkenazi Jews and Caucasians","volume":"19","author":"Hannah-Shmouni","year":"2017","journal-title":"Genet. Med."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0165","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1210\/jc.2013-1440","article-title":"Approach to the patient: the adult with congenital adrenal hyperplasia","volume":"98","author":"Auchus","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0170","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1001\/archpediatrics.2011.774","article-title":"Efficiency of neonatal screening for congenital adrenal hyperplasia due to 21-hydroxylase deficiency in children born in mainland France between 1996 and 2003","volume":"166","author":"Coulm","year":"2012","journal-title":"Arch. Pediatr. Adolesc. Med."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0175","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1530\/EJE-09-0145","article-title":"Transient hyper-17-hydroxyprogesteronemia: a clinical subgroup of patients diagnosed at neonatal screening for congenital adrenal hyperplasia","volume":"161","author":"Cavarzere","year":"2009","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0180","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1001\/jama.2012.5281","article-title":"Cases of congenital adrenal hyperplasia missed by newborn screening in Minnesota","volume":"307","author":"Sarafoglou","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0185","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jpeds.2005.04.035","article-title":"Newborn screening for congenital adrenal hyperplasia has reduced sensitivity in girls","volume":"147","author":"Varness","year":"2005","journal-title":"J. Pediatr."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0190","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1203\/01.PDR.0000142733.50918.6E","article-title":"Effect of single and multiple courses of prenatal corticosteroids on 17-hydroxyprogesterone levels: implication for neonatal screening of congenital adrenal hyperplasia","volume":"56","author":"Gatelais","year":"2004","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0195","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1210\/jc.2018-01865","article-title":"Congenital adrenal hyperplasia due to steroid 21-Hydroxylase deficiency: an endocrine society clinical practice guideline","volume":"103","author":"Speiser","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0200","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0022-4731(84)90382-0","article-title":"Development of plasma 21-deoxycortisol radioimmunoassay and application to the diagnosis of patients with 21-hydroxylase deficiency","volume":"21","author":"Milewicz","year":"1984","journal-title":"J. Steroid Biochem."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0205","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/j.1365-2265.2010.03871.x","article-title":"Superior discriminating value of ACTH-stimulated serum 21-deoxycortisol in identifying heterozygote carriers for 21-hydroxylase deficiency","volume":"73","author":"Costa-Barbosa","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0210","first-page":"587","article-title":"Zona fasciculata 21-hydroxysteroids and precursor-to-product ratios in 21-hydroxylase deficiency: further characterization of classic and non-classic patients and heterozygote carriers","volume":"34","author":"Costa-Barbosa","year":"2011","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0215","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1210\/jc.2015-1023","article-title":"Profiles of 21-carbon steroids in 21-hydroxylase deficiency","volume":"100","author":"Turcu","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0220","first-page":"810","article-title":"Clinical review 56: nonclassic adrenal hyperplasia: current concepts","volume":"78","author":"Azziz","year":"1994","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0225","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/01.OGX.0000062966.93819.5B","article-title":"Fertility in women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"58","author":"Stikkelbroeck","year":"2003","journal-title":"Obstet. Gynecol. Surv."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0230","first-page":"3070","article-title":"Long term outcome in adult males with classic congenital adrenal hyperplasia","volume":"86","author":"Cabrera","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0235","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1074\/jbc.273.6.3158","article-title":"Cytochrome b5 augments the 17,20-lyase activity of human P450c17 without direct electron transfer","volume":"273","author":"Auchus","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0240","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1172\/JCI115897","article-title":"Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"90","author":"Speiser","year":"1992","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0245","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1210\/jcem.85.3.6441","article-title":"Predicting phenotype in steroid 21-hydroxylase deficiency? Comprehensive genotyping in 155 unrelated, well defined patients from southern Germany","volume":"85","author":"Krone","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0250","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1210\/jc.2016-3989","article-title":"11-oxygenated androgens are biomarkers of adrenal volume and testicular adrenal rest tumors in 21-Hydroxylase deficiency","volume":"102","author":"Turcu","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0255","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1203\/00006450-198302000-00010","article-title":"Disproportionate suppression of dehydroepiandrosterone sulfate (DHEAS) in treated patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"17","author":"Rezvani","year":"1983","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0260","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0005-8165(73)80086-1","article-title":"The prepuberal and puberal growth of the adrenal (adrenarche)","volume":"150","author":"Dhom","year":"1973","journal-title":"Beitr. Pathol."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0265","first-page":"3695","article-title":"Adrenarche results from development of a 3beta-hydroxysteroid dehydrogenase-deficient adrenal reticularis","volume":"83","author":"Gell","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0270","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1677\/JOE-09-0127","article-title":"Development of the human adrenal zona reticularis: morphometric and immunohistochemical studies from birth to adolescence","volume":"203","author":"Hui","year":"2009","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0275","doi-asserted-by":"crossref","first-page":"4585","DOI":"10.1210\/jc.2016-2864","article-title":"Age-dependent increases in adrenal cytochrome b5 and serum 5-Androstenediol-3-sulfate","volume":"101","author":"Rege","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0280","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1111\/cen.12612","article-title":"Reference values for serum dehydroepiandrosterone-sulphate in healthy children and adolescents with emphasis on the age of adrenarche and pubarche","volume":"82","author":"Guran","year":"2015","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0285","first-page":"3570","article-title":"Apparent cortisone reductase deficiency: a functional defect in 11beta-hydroxysteroid dehydrogenase type 1","volume":"84","author":"Jamieson","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0290","first-page":"205","article-title":"11beta-hydroxysteroid dehydrogenase type 1 deficiency (\u2019apparent cortisone reductase deficiency\u2019) in a 6-year-old boy","volume":"59","author":"Malunowicz","year":"2003","journal-title":"Horm. Res."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0295","doi-asserted-by":"crossref","first-page":"K19","DOI":"10.1530\/EJE-12-0628","article-title":"Novel H6PDH mutations in two girls with premature adrenarche:\u2019 apparent\u2019 and\u2019 true\u2019 CRD can be differentiated by urinary steroid profiling","volume":"168","author":"Lavery","year":"2013","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0300","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1210\/jc.2008-0743","article-title":"Steroid biomarkers and genetic studies reveal inactivating mutations in hexose-6-phosphate dehydrogenase in patients with cortisone reductase deficiency","volume":"93","author":"Lavery","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0305","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1056\/NEJMoa0810489","article-title":"Inactivating PAPSS2 mutations in a patient with premature pubarche","volume":"360","author":"Noordam","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0310","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1096\/fasebj.11.1.9034160","article-title":"Sulfation and sulfotransferases 1: sulfotransferase molecular biology: cDNAs and genes","volume":"11","author":"Weinshilboum","year":"1997","journal-title":"FASEB J."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0315","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1210\/er.2001-0040","article-title":"Sulfonation and molecular action","volume":"23","author":"Strott","year":"2002","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0320","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1203\/00006450-197510000-00010","article-title":"Elevated urinary testosterone and androstanediol in precocious adrenarche","volume":"9","author":"Doberne","year":"1975","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0325","first-page":"671","article-title":"Premature adrenarche--normal variant or forerunner of adult disease?","volume":"21","author":"Ibanez","year":"2000","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0330","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1210\/jcem-42-6-1005","article-title":"Dehydroepiandrosterone sulfate (DS) levels, a rapid test for abnormal adrenal androgen secretion","volume":"42","author":"Korth-Schutz","year":"1976","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0335","first-page":"342","article-title":"Evidence for the adrenal source of androgens in precocious adrenarche","volume":"82","author":"Korth-Schutz","year":"1976","journal-title":"Acta Endocrinol. (Copenh.)"},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0340","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1365-2265.1995.tb01874.x","article-title":"\u2019Exaggerated adrenarche\u2019 in children presenting with premature adrenarche","volume":"42","author":"Likitmaskul","year":"1995","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0345","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0889-8529(18)30148-8","article-title":"Acne, hirsutism, and alopecia in adolescent girls. Clinical expressions of androgen excess","volume":"22","author":"Rosenfield","year":"1993","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0350","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0022-3476(82)80033-4","article-title":"Adrenarche as a cause of benign pseudopuberty in boys","volume":"101","author":"Rosenfield","year":"1982","journal-title":"J. Pediatr."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0355","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1210\/jcem-42-3-468","article-title":"Plasma adrenal and gonadal sex steroids in human pubertal development","volume":"42","author":"Ducharme","year":"1976","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0360","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1210\/jcem-42-1-117","article-title":"Serum androgens in normal prepubertal and pubertal children and in children with precocious adrenarche","volume":"42","author":"Korth-Schutz","year":"1976","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0365","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1210\/jc.2009-1670","article-title":"A novel ultrapressure liquid chromatography tandem mass spectrometry method for the simultaneous determination of androstenedione, testosterone, and dihydrotestosterone in pediatric blood samples: age- and sex-specific reference data","volume":"95","author":"Kulle","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0370","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1651-2227.1983.tb09798.x","article-title":"Benign premature adrenarche: clinical features and serum steroid levels","volume":"72","author":"Voutilainen","year":"1983","journal-title":"Acta Paediatr. Scand."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0375","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1515\/JPEM.2008.21.5.439","article-title":"Differences in endocrine parameters and psychopathology in girls with premature adrenarche versus on-time adrenarche","volume":"21","author":"Dorn","year":"2008","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0380","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/pr.2014.21","article-title":"Serum androgen bioactivity is low in children with premature adrenarche","volume":"75","author":"Liimatta","year":"2014","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0385","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1210\/jc.2015-3780","article-title":"Perspectives in polycystic ovary syndrome: from hair to eternity","volume":"101","author":"Dunaif","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0390","doi-asserted-by":"crossref","first-page":"E1519","DOI":"10.1073\/pnas.1400574111","article-title":"3rd, Overexpression of a DENND1A isoform produces a polycystic ovary syndrome theca phenotype","volume":"111","author":"McAllister","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0395","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13148-018-0442-y","article-title":"Aberrant expression and DNA methylation of lipid metabolism genes in PCOS: a new insight into its pathogenesis","volume":"10","author":"Pan","year":"2018","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0400","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","author":"The Rotterdam ESHRE\/ASRM\u2010sponsored PCOS consensus workshop group","year":"2004","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0405","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0015-0282(16)47961-6","article-title":"The prevalence and significance of elevated dehydroepiandrosterone sulfate levels in anovulatory women","volume":"42","author":"Hoffman","year":"1984","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0410","first-page":"2317","article-title":"Adrenal androgen excess in the polycystic ovary syndrome: sensitivity and responsivity of the hypothalamic-pituitary-adrenal axis","volume":"83","author":"Azziz","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0415","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1210\/jc.2013-3399","article-title":"Hyperandrogenemia predicts metabolic phenotype in polycystic ovary syndrome: the utility of serum androstenedione","volume":"99","author":"O\u2019Reilly","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0420","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1159\/000486036","article-title":"Fall, and resurrection of 11-oxygenated androgens in human physiology and disease","volume":"89","author":"Turcu","year":"2018","journal-title":"Horm. Res. Paediatr."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0425","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0015-0282(16)56940-4","article-title":"Ovarian suppression with triptorelin and adrenal stimulation with adrenocorticotropin in functional hyperadrogenism: role of adrenal and ovarian cytochrome P450c17 alpha","volume":"62","author":"Escobar-Morreale","year":"1994","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0430","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0029-7844(95)00065-Y","article-title":"Reassessment of adrenal androgen secretion in women with polycystic ovary syndrome","volume":"85","author":"Carmina","year":"1995","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0435","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1210\/jcem-62-5-840","article-title":"Adrenal androgen hyperresponsiveness to adrenocorticotropin in women with acne and\/or hirsutism: adrenal enzyme defects and exaggerated adrenarche","volume":"62","author":"Lucky","year":"1986","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0440","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0015-0282(16)54239-3","article-title":"11 beta-hydroxylase deficiency in hyperandrogenism","volume":"55","author":"Azziz","year":"1991","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0445","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0015-0282(16)55152-8","article-title":"The ratio of androstenedione:11 beta-hydroxyandrostenedione is an important marker of adrenal androgen excess in women","volume":"58","author":"Carmina","year":"1992","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0450","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/0002-9378(91)90042-P","article-title":"Is 11 beta-hydroxyandrostenedione a better marker of adrenal androgen excess than dehydroepiandrosterone sulfate?","volume":"165","author":"Stanczyk","year":"1991","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0455","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0015-0282(16)55317-5","article-title":"11 beta-hydroxyandrostenedione in plasma, follicular fluid, and granulosa cells of women with normal and polycystic ovaries","volume":"58","author":"Owen","year":"1992","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0460","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/S0015-0282(16)54006-0","article-title":"11 beta-hydroxyandrostenedione: a marker of adrenal function in hirsutism","volume":"54","author":"Hudson","year":"1990","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0465","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1210\/jcem-66-5-946","article-title":"Serum 11 beta-hydroxyandrostenedione as an indicator of the source of excess androgen production in women with polycystic ovaries","volume":"66","author":"Polson","year":"1988","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0470","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1210\/jc.2016-3285","article-title":"11-oxygenated C19 steroids are the predominant androgens in polycystic ovary syndrome","volume":"102","author":"O\u2019Reilly","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0475","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1507\/endocrj.EJ18-0212","article-title":"11-oxygenated C19 steroids as circulating androgens in women with polycystic ovary syndrome","volume":"65","author":"Yoshida","year":"2018","journal-title":"Endocr. J."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0480","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.1210\/jc.2017-00947","article-title":"AKR1C3-mediated adipose androgen generation drives lipotoxicity in women with polycystic ovary syndrome","volume":"102","author":"O\u2019Reilly","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0485","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1210\/jc.2013-2856","article-title":"Adjuvant therapies and patient and tumor characteristics associated with survival of adult patients with adrenocortical carcinoma","volume":"99","author":"Else","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0490","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1210\/er.2013-1029","article-title":"Adrenocortical carcinoma","volume":"35","author":"Else","year":"2014","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0495","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1210\/jcem-14-6-676","article-title":"Isolation of pregnane-3-alpha, 17-alpha, 21-triol-20-one (tetrahydro compound S) from the urine of a woman with metastatic adrenocortical carcinoma","volume":"14","author":"Touchstone","year":"1954","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0500","first-page":"656","article-title":"Steroid profile in urine: a useful tool in the diagnosis and follow up of adrenocortical carcinoma","volume":"122","author":"Grondal","year":"1990","journal-title":"Acta Endocrinol. (Copenh.)"},{"issue":"Suppl 1","key":"10.1016\/j.jsbmb.2019.01.018_bib0505","doi-asserted-by":"crossref","first-page":"194s","DOI":"10.1016\/S0753-3322(00)80043-8","article-title":"Urinary steroid profile in adrenocortical tumors","volume":"54","author":"Kikuchi","year":"2000","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0510","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1507\/endocrj1954.32.29","article-title":"Measurement of urinary steroid profile in patients with adrenal tumor as a screening method for carcinoma","volume":"32","author":"Minowada","year":"1985","journal-title":"Endocrinol. Jpn."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0515","first-page":"463","article-title":"Use of urinary steroid profiling for diagnosing and monitoring adrenocortical tumours","volume":"15","author":"Tiu","year":"2009","journal-title":"Hong Kong Med. J."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0520","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1159\/000184622","article-title":"Heterogeneity of urinary steroid profiles in children with adrenocortical tumors","volume":"44","author":"Malunowicz","year":"1995","journal-title":"Horm. Res."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0525","first-page":"381","article-title":"Steroid profile in serum: increased levels of sulphated pregnenolone and pregn-5-ene-3 beta,20 alpha-diol in patients with adrenocortical carcinoma","volume":"124","author":"Grondal","year":"1991","journal-title":"Acta Endocrinol. (Copenh.)"},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0530","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.1210\/jc.2011-1565","article-title":"Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumors","volume":"96","author":"Arlt","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0535","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s12672-015-0224-3","article-title":"Diagnostic value of urinary steroid profiling in the evaluation of adrenal tumors","volume":"6","author":"Kerkhofs","year":"2015","journal-title":"Horm. Cancer"},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0540","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1373\/clinchem.2017.271106","article-title":"High-resolution, accurate-mass (HRAM) mass spectrometry urine steroid profiling in the diagnosis of adrenal disorders","volume":"63","author":"Hines","year":"2017","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0545","article-title":"Steroid panels as a tool for the differential diagnosis of adrenocortical carcinoma vs. benign adrenal adenomas","author":"Rege","year":"2017","journal-title":"The 99th Meeting of the Endocrine Society"},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0550","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1373\/clinchem.2017.277624","article-title":"A 13-steroid serum panel based on LC-MS\/MS: use in detection of adrenocortical carcinoma","volume":"63","author":"Taylor","year":"2017","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0555","article-title":"Plasma steroid metabolome profiling for the diagnosis of adrenocortical carcinoma","author":"Schweitzer","year":"2018","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0560","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1158\/1078-0432.CCR-08-1067","article-title":"Molecular classification and prognostication of adrenocortical tumors by transcriptome profiling","volume":"15","author":"Giordano","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0565","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.mce.2015.04.022","article-title":"Immunohistochemical, genetic and clinical characterization of sporadic aldosterone-producing adenomas","volume":"411","author":"Monticone","year":"2015","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0570","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1210\/jc.2015-3284","article-title":"Clinical and steroidogenic characteristics of aldosterone-producing adenomas with ATPase or CACNA1D gene mutations","volume":"101","author":"Kitamoto","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0575","first-page":"873","article-title":"The unique steroidogenesis of the aldosteronoma in the differential diagnosis of primary aldosteronism","volume":"76","author":"Ulick","year":"1993","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0580","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/EJE-17-0563","article-title":"DIAGNOSIS OF ENDOCRINE DISEASE: 18-Oxocortisol and 18-hydroxycortisol: is there clinical utility of these steroids?","volume":"178","author":"Lenders","year":"2018","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0585","first-page":"3996","article-title":"Recombinant CYP11B genes encode enzymes that can catalyze conversion of 11-deoxycortisol to cortisol, 18-hydroxycortisol, and 18-oxocortisol","volume":"83","author":"Mulatero","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0590","doi-asserted-by":"crossref","first-page":"4628","DOI":"10.1210\/jc.2004-0379","article-title":"Studies on the origin of circulating 18-hydroxycortisol and 18-oxocortisol in normal human subjects","volume":"89","author":"Freel","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0595","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1210\/jc.2011-2384","article-title":"18-hydroxycorticosterone, 18-hydroxycortisol, and 18-oxocortisol in the diagnosis of primary aldosteronism and its subtypes","volume":"97","author":"Mulatero","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0600","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1440-1681.1996.tb02789.x","article-title":"Production of 18-oxo-cortisol in subtypes of primary aldosteronism","volume":"23","author":"Stowasser","year":"1996","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0605","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1161\/01.HYP.38.3.688","article-title":"Serum 18-hydroxycortisol in primary aldosteronism, hypertension, and normotensives","volume":"38","author":"Mosso","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0610","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1161\/HYPERTENSIONAHA.114.04453","article-title":"Measurement of peripheral plasma 18-oxocortisol can discriminate unilateral adenoma from bilateral diseases in patients with primary aldosteronism","volume":"65","author":"Satoh","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0615","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1373\/clinchem.2015.251199","article-title":"Mass spectrometry-based adrenal and peripheral venous steroid profiling for subtyping primary aldosteronism","volume":"62","author":"Eisenhofer","year":"2016","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0620","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1126\/science.1198785","article-title":"K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension","volume":"331","author":"Choi","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0625","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1210\/jc.2011-2885","article-title":"Expression and mutations of KCNJ5 mRNA in Japanese patients with aldosterone-producing adenomas","volume":"97","author":"Taguchi","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0630","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/ng.2550","article-title":"Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension","volume":"45","author":"Beuschlein","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0635","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1161\/HYPERTENSIONAHA.113.01733","article-title":"Somatic ATP1A1, ATP2B3, and KCNJ5 mutations in aldosterone-producing adenomas","volume":"63","author":"Williams","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0640","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/ng.2716","article-title":"Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension","volume":"45","author":"Azizan","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0645","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/ng.2695","article-title":"Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism","volume":"45","author":"Scholl","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0650","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1161\/HYPERTENSIONAHA.115.06186","article-title":"Genotype-specific steroid profiles associated with aldosterone-producing adenomas","volume":"67","author":"Williams","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0655","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1161\/HYPERTENSIONAHA.118.11465","article-title":"Immunohistopathology and steroid profiles associated with biochemical outcomes after adrenalectomy for unilateral primary aldosteronism","volume":"72","author":"Meyer","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0660","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0140-6736(14)61375-1","article-title":"Cushing\u2019s syndrome","volume":"386","author":"Lacroix","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0665","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1210\/jc.2008-0125","article-title":"The diagnosis of Cushing\u2019s syndrome: an endocrine society clinical practice guideline","volume":"93","author":"Nieman","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0670","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1210\/jcem-26-3-257","article-title":"Patterns of urinary excretion of steroids in Cushing\u2019s syndrome","volume":"26","author":"Martin","year":"1966","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0675","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/clinchem\/32.1.93","article-title":"Urinary excretion rates of 15 free steroids: potential utility in differential diagnosis of Cushing\u2019s syndrome","volume":"32","author":"Schoneshofer","year":"1986","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0680","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1093\/clinchem\/37.8.1329","article-title":"Serum profiles of steroid hormones in patients with Cushing\u2019s syndrome determined by a new HPLC\/RIA method","volume":"37","author":"Ueshiba","year":"1991","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0685","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1365-2265.1982.tb02757.x","article-title":"Investigation of urinary steroid profiles as a diagnostic method in Cushing\u2019s syndrome","volume":"16","author":"Phillipou","year":"1982","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0690","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1210\/JC.2015-1992","article-title":"Steroid profiling by LC-MS\/MS in nonsecreting and subclinical cortisol-secreting adrenocortical adenomas","volume":"100","author":"Di Dalmazi","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2019.01.018_bib0695","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1373\/clinchem.2017.282582","article-title":"Plasma steroid metabolome profiling for diagnosis and subtyping patients with cushing syndrome","volume":"64","author":"Eisenhofer","year":"2018","journal-title":"Clin. Chem."}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076018306952?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076018306952?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T00:04:03Z","timestamp":1760745843000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960076018306952"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":139,"alternative-id":["S0960076018306952"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2019.01.018","relation":{},"ISSN":["0960-0760"],"issn-type":[{"value":"0960-0760","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Steroid biomarkers in human adrenal disease","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2019.01.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}